Talk:Reshma Kewalramani

This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.

If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.

Articles for creation

	This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.Articles for creationWikipedia:WikiProject Articles for creationTemplate:WikiProject Articles for creationAfC articles
	This article was accepted from this draft on 13 April 2020 by reviewer MurielMary (talk · contribs).

Biography

This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography articles

Women scientists Low‑importance

	This article is within the scope of WikiProject Women scientists, a collaborative effort to improve the coverage of Women in science on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Women scientistsWikipedia:WikiProject Women scientistsTemplate:WikiProject Women scientistsWomen scientists articles
Low	This article has been rated as Low-importance on the project's importance scale.

Women in Business Low‑importance

	This article is within the scope of WikiProject Women in Business, a collaborative effort to improve the coverage of articles about women in business on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Women in BusinessWikipedia:WikiProject Women in BusinessTemplate:WikiProject Women in BusinessWomen in Business articles
Low	This article has been rated as Low-importance on the project's importance scale.

The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.

JohnDatVertex (talk · contribs) has been paid by Vertex Pharmaceuticals on behalf of Reshma Kewalramani.

Edit request to correct birth year, update the Career section, and correct the Personal life section[edit]

Part of an edit requested by an editor with a conflict of interest has been implemented.

Hi. I am John and I would like to request the following update and corrections to Reshma Kewalramani's page.

Kewalramani's year of birth is incorrect in two places; please change it to 1972 in the lead and in the Early life sections. This is the source. https://investors.vrtx.com/static-files/7bf5f528-b4ed-45c4-893d-bf9d98a53bb1. On page 24 of this source her age is listed as 49. Since the document is dated Dec. 31, 2021, that means that there is no ambiguity about how old she is on any day in 2021, even if her birthday is Dec. 31st, as of that last day of 2021 she was 49.
Please add the following paragraph to the end of the first paragraph of the Career section: Since she became CEO, Vertex has continued to research and develop therapies for multiple diseases including moving its cystic fibrosis,^[1] type 1 diabetes,^[2] APOL1-mediated kidney disease^[3]^[4] and pain programs into the clinic.^[2]^[5] The company has also partnered with CRISPR Therapeutics to develop gene-editing therapies for the treatment of sickle cell disease and beta thalassemia.^[6]
In the Personal life section, please remove "a daughter and" because Reshma only has twin sons and no daughter; there is no source that says she has a daughter.

References

^ Choudhary, Vidhi (10 March 2022). "Vertex Pharma Has a Cystic Fibrosis Drug That Rivals Envy". TheStreet.
^ ^a ^b Jason, Mast (24 March 2021). "Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories 'again and again and again'?". Endpoints News.
^ Armstrong, Madeleine (1 December 2021). "Vertex finally catches a break". Evaluate Vantage.
^ Pagliarulo, Ned (22 March 2022). "Vertex plans path to FDA for top drug prospect". BioPharmaDive.
^ Fidler, Ben (22 September 2021). "This is the time to double down': Top Vertex executives defend research plan as pressure builds". BioPharmaDive.
^ Garde, Damian (11 June 2021). "A CRISPR treatment for blood diseases shows curative promise in small study". STAT News.

Thank so much for your help, JohnDatVertex (talk) 17:40, 8 April 2022 (UTC)[reply]

Partly done: Removed the year, given the source did not include it. Neither did it give a date, so it's best to not include a DOB until a reliable source is provided (yours isn't independent). Added your requested paragraph, with substantial edits, and also withdrew the daughter statement. PK650 (talk) 23:20, 18 April 2022 (UTC)[reply]

Thanks so much PK650 for implementing my above edit request. However, the incorrect birth year also appears at the beginning of the "Early life" section, and should be removed from there as well. The article was also incorrectly added to the "1973 births" category, so that incorrect category should also be removed.

One additional request I have is to remove the mention of "RIZE Massachusetts" in the Boards and awards section, since she no longer is a board member there. You can check that here: https://www.rizema.org/board/

One last issue is that reference #14 has a "Cite error" warning, which should probably be fixed. Once again, thanks so much for your help. JohnDatVertex (talk) 12:45, 20 April 2022 (UTC)[reply]

Thank you for letting me know. Fixed. PK650 (talk) 01:02, 23 April 2022 (UTC)[reply]

Thanks again PK650 for your edits. Now that the incorrect birthday has been removed entirely from the article, I hope you don’t mind if I remove the category template "1973 births" directly. Thanks again. JohnDatVertex (talk) 12:58, 25 April 2022 (UTC)[reply]

Updates to Boards and awards[edit]

This edit request by an editor with a conflict of interest has now been answered.

Hi. The "Boards and awards" section needs updating with the following sourced content:

Please add the following as a new first paragraph to the Boards and awards section:

Kewalramani is a member of the Massachusetts General Hospital Board of Trustees, the Biomedical Science Careers Program Board^[1] and the Boston University School of Medicine Dean's Advisory Board.^[2]^[3] She is also a member of the board of directors of Ginkgo Bioworks,^[4] and was on the inaugural board of directors of the Kidney Health Initiative.^[5]

Please remove the following sentence from the already existing paragraph, (what is now the second paragraph), since this information is included in the new first paragraph above:

"She is a member of the board of directors of the Biomedical Science Careers Program and sits on the Boston University School of Medicine Dean's Advisory Committee."

Please add the following to the end of the second paragraph: (the pre-existing paragraph-change the period after the word Indiaspora to a comma):

Business Insider’s list of 10 people transforming health care,^[6] the PharmaVOICE 100 list of leaders in the life sciences,^[7] and Boston Business Journal’s list of Women Who Mean Business.^[8] In 2021, she was the recipient of the International Institute of New England’s Golden Door Award and was named a New Englander of the Year by the New England Council.^[9] Under her leadership as CEO, Vertex was ranked #2 on The Commonwealth Institute’s Top Women-Led Businesses in Massachusetts in 2021.^[10]

References

^ "Leadership". BSCP.com.
^ "Giving/Board of Trustees". giving.massgeneral.org.
^ "BUSM Dean's Advisory Board". bumc.bu.edu.
^ "Vertex CEO Dr. Kewalramani to Join Ginkgo Board". ginkgobioworks.com. Ginkgo Bioworks. 3 August 2021.
^ "Dr. Reshma Kewalramani named incoming president and CEO of Vertex Pharmaceuticals, former member ASN KHI Board of Directors". Kidney News Online. 26 July 2019.
^ Lee, Vivian S. (2020). "100 People Transforming Business in North America". Business Insider.
^ "PharmaVOICE 100 Who's on the List - By Category". PharmaVOICE. 1 August 2020.
^ "Here are the BBJ's 2020 Women Who Mean Business honorees". Boston Business Journal. 15 October 2020.
^ "NEC to Honor Historic All-Female Lineup of 2021 New Englanders of the Year". The New England Council. 2021.
^ "The 2021 Top 100 Women-Led Businesses". Boston Globe. 5 November 2021.

Thanks so much. I am pinging PK650 who has been helpful in the past. JohnDatVertex (talk) 19:21, 12 May 2022 (UTC)[reply]

Done -Kj cheetham (talk) 10:34, 9 July 2022 (UTC)[reply]

Hi Kj cheetham, Thanks for implementing my edit request, and inviting me to learn more about editing Wikipedia. I don’t know if I will ever have the time to contribute more to Wikipedia, but it is certainly something I will consider. With appreciation, JohnDatVertex (talk) 18:58, 11 July 2022 (UTC)[reply]

Infobox[edit]

Hi. I noticed the new Infobox and decided to fix it up a bit, including adding some information. I am happy to discuss if anyone has any questions. JohnDatVertex (talk) 20:41, 30 January 2024 (UTC)[reply]

[1] Choudhary, Vidhi (10 March 2022). "Vertex Pharma Has a Cystic Fibrosis Drug That Rivals Envy". TheStreet.

[:5-2] Jason, Mast (24 March 2021). "Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories 'again and again and again'?". Endpoints News.

[3] Armstrong, Madeleine (1 December 2021). "Vertex finally catches a break". Evaluate Vantage.

[4] Pagliarulo, Ned (22 March 2022). "Vertex plans path to FDA for top drug prospect". BioPharmaDive.

[5] Fidler, Ben (22 September 2021). "This is the time to double down': Top Vertex executives defend research plan as pressure builds". BioPharmaDive.

[STAT_News:_A_CRISPER-6] Garde, Damian (11 June 2021). "A CRISPR treatment for blood diseases shows curative promise in small study". STAT News.

[BSCP1-7] "Leadership". BSCP.com.

[MassGeneralHosp1-8] "Giving/Board of Trustees". giving.massgeneral.org.

[BUSM1-9] "BUSM Dean's Advisory Board". bumc.bu.edu.

[ginkgo1-10] "Vertex CEO Dr. Kewalramani to Join Ginkgo Board". ginkgobioworks.com. Ginkgo Bioworks. 3 August 2021.

[Kidney_News1-11] "Dr. Reshma Kewalramani named incoming president and CEO of Vertex Pharmaceuticals, former member ASN KHI Board of Directors". Kidney News Online. 26 July 2019.

[BusinessInsider1-12] Lee, Vivian S. (2020). "100 People Transforming Business in North America". Business Insider.

[PharmaVOICE1-13] "PharmaVOICE 100 Who's on the List - By Category". PharmaVOICE. 1 August 2020.

[BBJ1-14] "Here are the BBJ's 2020 Women Who Mean Business honorees". Boston Business Journal. 15 October 2020.

[NewEnglandCouncil1-15] "NEC to Honor Historic All-Female Lineup of 2021 New Englanders of the Year". The New England Council. 2021.

[Boston_Globe1-16] "The 2021 Top 100 Women-Led Businesses". Boston Globe. 5 November 2021.

[1]

[2]

[3]

[4]

[5]

[6]

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]